- Home
- JAZZ vs ZWS Comparison
JAZZ vs ZWS Comparison
Compare JAZZ & ZWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- ZWS
- Stock Information
- Founded
- JAZZ 2003
- ZWS 1891
- Country
- JAZZ Ireland
- ZWS United States
- Employees
- JAZZ N/A
- ZWS N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- ZWS Industrial Machinery/Components
- Sector
- JAZZ Health Care
- ZWS Industrials
- Exchange
- JAZZ Nasdaq
- ZWS Nasdaq
- Market Cap
- JAZZ 6.7B
- ZWS 5.9B
- IPO Year
- JAZZ 2007
- ZWS 2012
- Fundamental
- Price
- JAZZ $110.27
- ZWS $37.79
- Analyst Decision
- JAZZ Strong Buy
- ZWS Buy
- Analyst Count
- JAZZ 12
- ZWS 6
- Target Price
- JAZZ $183.08
- ZWS $37.67
- AVG Volume (30 Days)
- JAZZ 651.1K
- ZWS 740.7K
- Earning Date
- JAZZ 07-30-2025
- ZWS 07-29-2025
- Dividend Yield
- JAZZ N/A
- ZWS 0.95%
- EPS Growth
- JAZZ 49.21
- ZWS 40.41
- EPS
- JAZZ 7.51
- ZWS 0.98
- Revenue
- JAZZ $4,064,808,000.00
- ZWS $1,581,500,000.00
- Revenue This Year
- JAZZ $6.05
- ZWS $4.31
- Revenue Next Year
- JAZZ $4.68
- ZWS $4.65
- P/E Ratio
- JAZZ $14.72
- ZWS $38.58
- Revenue Growth
- JAZZ 5.76
- ZWS 3.22
- 52 Week Low
- JAZZ $95.49
- ZWS $27.74
- 52 Week High
- JAZZ $148.06
- ZWS $41.15
- Technical
- Relative Strength Index (RSI)
- JAZZ 52.75
- ZWS 61.61
- Support Level
- JAZZ $109.27
- ZWS $36.77
- Resistance Level
- JAZZ $112.70
- ZWS $38.49
- Average True Range (ATR)
- JAZZ 2.72
- ZWS 0.68
- MACD
- JAZZ 0.42
- ZWS 0.12
- Stochastic Oscillator
- JAZZ 67.81
- ZWS 78.33
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About ZWS Zurn Elkay Water Solutions Corporation
Zurn Elkay Water Solutions Corp designs procures, manufactures, and markets a range of clean water solutions for drinking water, hygiene, and sustainable water management. The company's product portfolio includes professional-grade water control and safety, water distribution and drainage, drinking water, finish plumbing, hygienic, environmental and site works products for public and private spaces.